Development of an immundiagnostic rapid-test for cancer diseases in dogs - clinical verification study

Important results from the project

** Denna text är maskinöversatt ** Objective for the project 1 Scientifically evaluate Alertix TK1 ELISAs´s usefulness in various cancer diseases 2 Establish collaboration with world-leading veterinary oncology expertise

Expected long term effects

** Denna text är maskinöversatt ** 1 An optimized test system has been developed based on a newly established biobank. The experimental objectives of the project have largely been achieved, although the results have not fully met expectations 2 The goal of the project to establish a collaboration with a leading oncology veterinary clinic in North America has thus been met

Approach and implementation

** Denna text är maskinöversatt ** Frozen serum samples from dogs with various cancers have been obtained from an American veterinary oncology clinic. Together with serum samples from both cancer patients and healthy dogs from Universitetsdjursjukhuset SLU, Uppsala, analyzes have been performed at the Alertix lab Work is underway in the autumn of 2020 to complete and submit manuscripts for scientific publication

External links

Sidan är generell för Alertix och beskriver inte projektet specifikt